Merieme Klobocista, MD, of Hackensack Meridian Health explains how molecular testing is personalizing treatment for ovarian and uterine cancer.
Merieme Klobocista
Advertisement
Articles by Merieme Klobocista
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Onc
1
JNJ-6143 Elicits PSA Responses in Heavily Pretreated mCRPC
2
Chidamide Plus Nivolumab Shows Potential Frontline Role in Melanoma
3
Late-Breaking Breast Cancer Data at ESMO 2026 Highlight ADCs and Ribociclib
4
Real-World Data Support Outpatient Tarlatamab for Community SCLC Care
5